Stock market. Stocks. IPO of Spruce Biosciences (SPRB) — on October 09, 2020, shares of a Company developing new treatments for rare endocrine diseases will start trading on the American stock exchange. The placement is underwritten by Cowen, SVB Leerink, Credit Suisse and RBC Capital Markets. The deadline for submitting an application with the broker is 20-00 Moscow time 07.10.2020, the placement date is 08.10.20
2% of the Fund will be invested in shares of this company. A detailed report on the transaction, or "opportunity card", for all partners of our Fund will be provided in PDF format. Anyone who wants to receive them is asked to write with private messages.